SD-WAN Market Leader, Aryaka, Releases First EMEA Edition of its State of SD-WAN Connectivity Report
Research finds up to 20x cloud and SaaS application performance improvements when connecting via private network-based SD-WANs versus the public Internet
LONDON, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, has released its first EMEA Edition of the State of SD-WAN Connectivity report that analyses the performance of SD-WAN deployments over the Internet as compared with those delivered over global private networks. The report highlights specific application response times between various European, Middle East, Asia-Pacific and Americas locations, as well as key factors that impact the performance of cloud and SaaS applications.
This research helps IT leaders in Europe, Middle East and Africa (EMEA) to evaluate the best underlying connectivity for their SD-WAN deployments to ensure fast, reliable and consistent performance for all on-premises, cloud and SaaS applications, including voice, video, and data. The report reveals significant differences in both average response times and variations in application response times when comparing the performance between SD-WANs that run over the public Internet, and SD-WANs built on a cloud-native private network, such as Aryaka.
From an EMEA perspective, the performance differentials are significant:
When comparing file transfers, private network-based SD-WANs proved far more consistent than Internet-based SD-WANs. Lower variations in application response times help deliver a more consistent user experience.
· A London-Dubai link had 14.5x less variation using the Aryaka global private network compared to the public Internet.
· Dubai-Dallas was 12.5x less variable on Aryaka's global private network, while Dubai-Mumbai was 13.7x less variable.
· Frankfurt-Chennai proved 3.2x more consistent on the global private network.
· While the Dubai-Johannesburg link had 96.23% variation in application response times over the Internet, the variation over Aryaka's global private network was only 0.25%, a huge improvement.
Global private networks also shrink inter-regional application response times.
· While in-region performance is improved using a global private network with London-Frankfurt links proving 43% faster, inter-regional time improvements were even more impressive.
· Frankfurt-Chennai and Dubai-Dallas links showed around 3x performance improvements.
· Frankfurt-Shanghai and Dubai-Beijing links were almost 10x faster on Aryaka's global private network compared to the public Internet, while London-Dubai application response times were 22x faster.
"While the Internet can be acceptable for users accessing cloud/SaaS applications within a region, application performance and user experience can deteriorate significantly when greater distances are involved," said Jason Wells, Aryaka's Vice President for EMEA & APAC. "For global organisations headquartered in EMEA expecting fast and consistent performance from their cloud/SaaS applications regardless of where they are hosted or where business users are located, the results of our EMEA State of SD-WAN Connectivity report should prove useful. IT leaders in global enterprises must deploy an SD-WAN solution with a cloud-native private network, such as Aryaka, if they want to ensure real-time delivery of their mission-critical applications."
Aryaka's research also confirmed that there are particular challenges facing EMEA-based organisations, particularly when connecting from EMEA countries to the APAC region over the Internet. Dubai, particularly, proved a challenging destination, for example, with a peak 261% variation when connecting from Dubai to Singapore.
This research follows Aryaka's third State of the WAN Report, which closely analyses annual enterprise WAN traffic and trends, challenges in application performance, WAN reliability and bandwidth access between specific geographies and industries from a worldwide perspective.
Aryaka's global SD-WAN helps international enterprises deliver improved performance for cloud and on-premises applications to enterprise datacenters, branch offices, and remote or mobile employees from anywhere in the world. For enterprises that have branch offices in EMEA, Aryaka's global SD-WAN also allows them to remain compliant with existing and upcoming regulatory requirements. This is because all enterprise data traversing Aryaka's global cloud-native private network is encrypted end-to-end. Moreover, there is no permanent data storage and all transient data storage is encrypted. Aryaka also has the ability to enforce policies to prohibit data transfers to countries outside of the European Economic Area (EEA).
Aryaka's global SD-WAN solution is currently deployed at more than 700 global enterprises with sites in 63 countries, and has quickly become the only viable MPLS replacement solution in the market today.
Download the full 'State of SD-WAN Connectivity - EMEA Edition' report here.
Application response times were measured and compared between various pairs of locations globally, both over Aryaka's global private network and the public Internet. Using a randomly generated 100KB file, Aryaka evaluated both the average application response time and the variation in application response times to report performance over each network.
Aryaka is transforming how global enterprises connect sites and users worldwide, and use mission-critical applications to support modern business execution demands. Aryaka's Global SD-WAN combines a purpose-built private network, SD-WAN, optimisation and acceleration techniques, connectivity to cloud platforms, and network visibility in a single solution that is delivered as a service.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aryaka via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
VITEC's EZ TV Video Wall Solution Wins Best of Show Award at the 2018 NAB Show26.4.2018 19:00 | Pressemelding
VITEC's EZ TV Video Wall Solution Wins Best of Show Award at the 2018 NAB Show SUNNYVALE, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- VITEC, a worldwide leader in advanced video encoding and streaming solutions, today announced that the new EZ TV video wall processor, available within the award-winning EZ TV IPTV and Digital Signage Platform, was recognized with a Best of Show Award at the 2018 NAB Show from Sound & Video Contractor (SVC) magazine. Evaluated by a panel of industry experts, the Best of Show Award winners were selected based on innovation, feature set, cost efficiency, and performance in serving the industry. VITEC's video wall solution is designed to simplify deployment and management of projects involving IPTV, digital signage, and video wall content, while delivering a breathtaking visual experience. The new EZ TV video wall processors are 100 percent hardware-based, feature low-latency native playback of IPTV streams up to 4K, and support interactive content, video, a
Inspiration in Receipt of Crypto Currency Proposal26.4.2018 16:54 | Pressemelding
TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- Inspiration Mining Corporation ("Inspiration" or the "Corporation") (CSE:ISM) is pleased to announce that it is contemplating upon the request of Compassion Cannabis that it is allowed to accept crypto currency for settlement for any transactions that occur. The logic is that it would make for easy settlement in any jurisdiction. The Company is not adverse to this proposal, but must perform its due diligence and will table the matter at the AGM. Compassion Cannabis is an Ontario Corp., which has expertise to forward various facets of the explosive new market of the marijuana industry, including but not limited to the "Vape" market and dispensary centers for the industry. We believe this will be an extremely lucrative space with tremendous demand in the medical cannabis industry. For further information, please contact Randy Miller, Chief Executive Officer of the Corporation, at tel: 416-842-9000, www.inspirationmining.com The CSE has not revi
SNOMED International Announces Brazil as its 33rd Member26.4.2018 15:12 | Pressemelding
London, United Kingdom, April 26, 2018 (GLOBE NEWSWIRE) -- Brazil's Ministry of Health and SNOMED International announce that as of April 1, 2018, Brazil has joined the organization as SNOMED International's thirty-third Member. With SNOMED CT already used in various parts of the country, Brazil joined SNOMED International to support nationwide health system transformation as a foundational element of its ehealth Strategy, digiSUS. As outlined in this national strategy, the SUS Monitoring and Evaluation Department of Brazil's Ministry of Health is responsible overall for governance of the National Electronic Health Strategy and its related evaluation and development. Demonstrated through its membership in SNOMED International, Brazil has defined SNOMED CT as the chosen international reference terminology for use in its clinical systems supporting the national ehealth strategy. SNOMED CT is the world's most comprehensive health terminology. Founded in 2007 by nine charter nations, SNOME
Minerva Neurosciences to Report First Quarter 2018 Financial Results and Business Updates on May 3, 201826.4.2018 14:30 | Pressemelding
Management to host conference call WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the first quarter of 2018 on Thursday, May 3, 2018. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 for domestic callers or (765) 507-2618 for international callers and referring to conference ID number 8885379. A live webcast of the conference call will be available online in the Investors and Media section of the Company's website at ir.minervaneurosciences.com. The archived webcast will be available on the Company's website beginning approximately two hours after the event for 30 days. About Minerva Neurosciences Mine
Talend Data Fabric Now Certified on MapR Converged Data Platform Version 6.026.4.2018 14:11 | Pressemelding
Latest Release of Talend's Data Integration Platform Enables Powerful New Use Cases in Data Privacy, Compliance Monitoring, Claims Processing, Retail Optimization, and More REDWOOD CITY, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Talend (NASDAQ: TLND), a global leader in cloud and big data integration solutions, announced that the latest version of Talend Data Fabric is now certified for version 6.0 of the MapR Converged Data Platform, including MapR-DB and MapR-FS. The MapR Converged Data Platform is the industry's only enterprise-grade software solution that unifies big data and open source technologies with fast, native access to global event streaming, real-time database capabilities, and web-scale storage. Together, Talend and MapR provide a unified, open source-based data storage and management platform for an array of different applications, enabling organizations to harness big data in valuable ways to drive innovation and further their digital transformations. "Talend's powerf
CrownBio Launches New Humanized Target Model for Immunotherapy26.4.2018 14:00 | Pressemelding
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, enhances its existing portfolio of humanized drug target models (HuGEMM(TM)) by launching a new transgenic CD3E model to advance development of immuno-oncology (I/O) drugs. Novel therapeutic T-cell redirecting antibodies, including bispecific T cell engagers, show great promise in effectively treating cancer. However, development of these drugs is hampered by a lack of in vivo models that can accurately recapitulate human specific responses. CrownBio addresses this need with their new CD3E transgenic model that was validated in collaboration with and developed by NBRI of Nanjing University. The CD3E model expresses the human form of CD3E and is phenotypically normal with levels
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom